R.A. Abdoellakhan, MSc

Research

Publications
  1. Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate

    Brekelmans, M. P. A., Abdoellakhan, R. A., Scheres, L. J. J., Biedermann, J. S., Hutten, B. A., Meijer, K., ten Cate, H., Huisman, M., Kruip, M. J. H. A., Middeldorp, S. & Coppens, M., Jan-2018, In : Research and practice in thrombosis and haemostasis. 2, 1, p. 77-84 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)

    Abdoellakhan, R. A., Khorsand, N., Van Hest, R. M., Veeger, N., Ter Avest, E., Ypma, P. F., Faber, L. M. & Meijer, K., 14-Mar-2018, In : BMJ Open. 8, 3, 7 p., e020764.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis

    Abdoellakhan, R. A., Miah, I. P., Khorsand, N., Meijer, K. & Jellema, K., Feb-2017, In : Neurocritical care. 26, 1, p. 64-69 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients

    van Maarseveen, E., van Buul-Gast, M-C., Abdoellakhan, R., Gelinck, L., Neef, C. & Touw, D., Sep-2014, In : Journal of Antimicrobial Chemotherapy. 69, 9, p. 2581-2583 3 p., dku175.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (4) »

View graph of relations

ID: 13170012